Clinical Trial Update: Pharmacokinetics of MB-102 and Use of the Non-invasive Optical Renal Function Monitor (ORFM) Device in Subjects With Normal and Impaired Renal Function and a Range of Skin Color Types [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating pharmacokinetics of MB-102 and the non-invasive Optical Renal Function Monitor (ORFM) in subjects with normal and impaired ren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• MB-102

Snippet

Sponsor: MediBeacon | Conditions: Acute Kidney Injury | Phase 2 | Status: COMPLETED | Results posted: 2023-10-26